FDA hustles through a quick OK for Shionogi’s new thrombocytopenia drug

The FDA has whisked through a new drug for thrombocytopenia patients.

The therapy is lusutrombopag (Mulpleta), which handily beat the August 26 PDUFA date that the FDA had handed Shionogi when it accepted the drug for a priority review schedule back in February.